CervoMed Inc. Logo

CervoMed Inc.

A clinical-stage biotech developing treatments for age-related neurologic disorders.

CRVO | US

Overview

Corporate Details

ISIN(s):
US2537484048 (+1 more)
LEI:
Country:
United States of America
Address:
20 PARK PLAZA, 2116 BOSTON

Description

CervoMed Inc. is a clinical-stage biotechnology company that develops treatments for age-related neurologic disorders. The company focuses on neurodegenerative diseases, including Dementia with Lewy Bodies (DLB), Alzheimer's, and Huntington's disease. Its lead investigational candidate is neflamapimod, an orally administered, small molecule brain penetrant that inhibits the p38 alpha protein kinase. CervoMed's scientific approach is based on early intervention to reverse synaptic dysfunction, which is considered a reversible aspect of the neurodegenerative process, before the onset of irreversible nerve cell death. The company is advancing neflamapimod through clinical trials, including a Phase 2 study for patients with DLB.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2010-04-14 18:48
STRATUS MEDIA GROUP, INC. 8-K
English 8.6 KB
2010-03-30 22:46
STRATUS MEDIA GROUP, INC. NT 10-K
English 9.4 KB
2010-02-26 17:18
STRATUS MEDIA GROUP, INC. 8-K
English 24.9 KB
2010-02-22 17:45 English 43.6 KB
2010-02-22 17:34 English 5.2 KB
2010-01-22 13:42 English 53.1 KB
2009-12-15 18:37 English 24.5 KB
2009-12-08 18:05 English 5.2 KB
2009-12-02 18:00
STRATUS MEDIA GROUP, INC. 8-K
English 8.1 KB
2009-11-19 18:30
STRATUS MEDIA GROUP, INC. 10-Q
English 108.8 KB
2009-11-19 17:04
STRATUS MEDIA GROUP, INC. 10-Q/A
English 108.3 KB
2009-11-16 14:20
STRATUS MEDIA GROUP, INC. NT 10-Q
English 9.6 KB
2009-11-12 07:30 English 4.5 KB
2009-11-05 15:57
PRIMARY DOCUMENT
English 5.8 KB
2009-10-21 21:16
STRATUS MEDIA GROUP, INC. 8-K
English 86.3 KB

Automate Your Workflow. Get a real-time feed of all CervoMed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CervoMed Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CervoMed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480
CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.